Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 265
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
Comparing Psilocybin Mushroom Bruising with Trichoderma Infection
PT250 – Matt Ball – New Frameworks For Schizophrenia, Dissociation, and...
Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and...
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in...
Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board
Awakn Life Sciences Files Patent Applications In U.S. For AWKN001 And...
MindMed Included in FTSE Russell 3000® Index
Psychedelic Bulletin: Ex-FDA Psychiatry Director Joins Cybin as Advisor; Texas Approves...
Psychedelic Treatment for Eating Disorder Recovery
PTSF65 – Navigating Psychedelics for Clinicians and Therapists, and Nitrous Oxide...
Load more
